Abstract: . . .  2003;361:2005-16. 4. Cannon CP, Braunwald E, McCabe CH, et al. Comparison of intensive and moderate lipid lowering with statins following acute coronary syndrome. N Engl J Med 2004;350:1495-1504. 5. Nissen SE, Tuzcu EM, Schoenhagen . . .
. . .  5. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid- lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-80. N:\MedAff\Afiles\VOCI\Active . . .
. . .  P, et al. Effect of intensive compared with moderate lipid- lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-80. N:\MedAff\Afiles\VOCI\Active Documents\Alert-LDL Cholesterol-How . . .
. . .  Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid- lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-80. N:\MedAff\Afiles\VOCI\Active Documents\Alert-LDL . . .
. . .  Given all the above, what is a reasonable, evidence based approach to statin therapy, LDL cholesterol reduction, and the secondary prevention of heart disease ? After reviewing the literature and consulting with Dean cardiologists, endocrinologists, . . .
. . .  the above, what is a reasonable, evidence based approach to statin therapy, LDL cholesterol reduction, and the secondary prevention of heart disease ? After reviewing the literature and consulting with Dean cardiologists, endocrinologists, primary . . .
--1559,6,130,2014,7795